|
WO2021019523A1
|
|
A process for the preparation of cariprazine salt
|
|
WO2021053651A1
|
|
Extract of cocculus hirsutus for treatment of covid-19
|
|
US2021038539A1
|
|
Infusion dosage form of norepinephrine
|
|
US2021121517A1
|
|
Stable parenteral dosage form of cetrorelix acetate
|
|
US2020268606A1
|
|
Infusion bag of midazolam for intravenous use
|
|
WO2020148609A1
|
|
A stable aqueous injectable solution of epinephrine
|
|
WO2020115723A1
|
|
Use of cocculus hirsutus extract for treating dengue
|
|
WO2020044311A1
|
|
Parenteral dosage form of carboplatin
|
|
WO2020021567A1
|
|
Injection device of fentanyl
|
|
WO2019193576A1
|
|
Novel glp-1 analogues
|
|
WO2019186429A1
|
|
A process for the preparation of bosutinib
|
|
WO2019166987A1
|
|
A process for the preparation of ribociclib and its intermediates
|
|
US10532049B1
|
|
Parenteral unit dosage form of dihydroergotamine
|
|
WO2019159097A1
|
|
Crystalline polymorphic forms of acalabrutinib
|
|
WO2019111160A1
|
|
Crystalline forms of ribociclib succinate
|
|
WO2019106692A1
|
|
Oral suspension of nintedanib esylate
|
|
WO2019087212A1
|
|
Intravenous infusion dosage form for morphine
|
|
WO2019087069A2
|
|
Pimavanserin tartrate impurities, processes for their preparation, and their use as reference standards
|
|
US2019105262A1
|
|
Intravenous infusion dosage form for pemetrexed
|
|
US2020190117A1
|
|
Process for the preparation of ixazomib citrate
|
